Skip to main content
OpenTrials

Clinical trial condition

Relapsed Cancer

Explore clinical trials studying Relapsed Cancer. Study availability and eligibility vary by location and protocol.

21 public trials 12 recruiting studies
Refine in advanced search Browse all conditions

Relapsed Cancer trial results

Recruiting

A Study to Investigate Safety and Effectiveness of BGB-16673 in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies

NCT06634589

Conditions
B-cell Lymphoma, B-cell Malignancy, Disease Attributes, +15 more
Locations
  • Mayo Clinic Phoenix Phoenix, Arizona, United States
  • University of Southern California Norris Comprehensive Los Angeles, California, United States
  • Mayo Clinic Jacksonville Jacksonville, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View all 50 locations
View Trial Details
Recruiting

Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma

NCT05852717

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
Locations
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center Indianapolis, Indiana, United States
  • Karmanos Cancer Center (Wayne State University) Detroit, Michigan, United States
  • University of Texas Southwestern Medical Center Dallas, Texas, United States
  • University of Virginia Health System Charlottesville, Virginia, United States
View Trial Details
Recruiting

Pembrolizumab, Ibrutinib and Rituximab in PCNSL

NCT04421560

Conditions
Disease Attributes, Neoplasms, Pathologic Processes, +6 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Columbia University Medical Center New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details

Related conditions